Nrf2 Activator RS9 Suppresses Pathological Ocular Angiogenesis and Hyperpermeability-Reference-Cited by-同舟云学术

Nrf2 Activator RS9 Suppresses Pathological Ocular Angiogenesis and Hyperpermeability

Published:2019-05-03 Issue:6 Volume:60 Page:1943
ISSN:1552-5783
Container-title:Investigative Opthalmology & Visual Science
language:en
Short-container-title:Invest. Ophthalmol. Vis. Sci.

Author:

Nakamura Shinsuke¹,Noguchi Tetsuro²³,Inoue Yuki¹,Sakurai Shuji¹,Nishinaka Anri¹,Hida Yoshifumi¹,Masuda Tomomi¹,Nakagami Yasuhiro⁴,Horai Naoto²³,Tsusaki Hideshi²⁴,Hara Hideaki¹²,Shimazawa Masamitsu¹²

Affiliation:

1. Molecular Pharmacology, Department of Biofunctional Evaluation, Gifu Pharmaceutical University, Gifu, Japan

2. Biomedical Research, Gifu Pharmaceutical University, Gifu, Japan

3. Shin Nippon Biomedical Laboratories Ltd. Drug Safety Research Laboratories (SNBL DSR), Kagoshima, Japan

4. Daiichi Sankyo Co., Ltd., Tokyo, Japan

Publisher

Association for Research in Vision and Ophthalmology (ARVO)

Subject

General Medicine

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Regulatory factors of Nrf2 in age-related macular degeneration pathogenesis;International Journal of Ophthalmology;2024-07-18

2. Syringaresinol Alleviates Early Diabetic Retinopathy by Downregulating HIF‐1α/VEGF via Activating Nrf2 Antioxidant Pathway;Molecular Nutrition & Food Research;2024-02

3. Recent Advances in Our Understanding of Age-Related Macular Degeneration: Mitochondrial Dysfunction, Redox Signaling, and the Complement System;aging and disease;2024

4. Association of TAS2R16 gene (rs860170, rs978739, rs1357949) polymorphisms and TAS2R16 serum levels in patients with age-related macular degeneration;Ophthalmic Genetics;2023-12-18

5. Protective effect of ethyl ferulate against hypoxic injury in retinal cells and retinal neovascularization in an oxygen-induced retinopathy model;Phytomedicine;2023-12